News & Updates
Showing Gastroenterology articles
Showing
Show Multimedia Only

Treatment failure risk in older IBD patients higher with vedolizumab vs TNF antagonists
25 Oct 2022
The use of vedolizumab in the treatment of older patients with inflammatory bowel disease (IBD) appears to not only pose a higher risk of treatment failure but also offer no significant safety advantage when compared with tumour necrosis factor (TNF) antagonists, according to a study.
25 Oct 2022







